Lung cancer trials in Brazil

In Brazil 68 Also abroad 2747

68 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Where
Barretos, Porto Alegre, São José do Rio Preto, São Paulo
Age
18 years and over
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07286149 · EU 2024-512248-47-00
Phase 3Taking people
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Where
Barretos, Belo Horizonte, Porto Alegre, São José do Rio Preto, São Paulo
Age
18 years and over
People
450 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT06765109 · EU 2024-517553-26-00
Phase 3Taking people
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Where
Blumenau, Fortaleza, Ijuí, Itajaí, Londrina, Passo Fundo, Porto Alegre, Porto Velho, Salvador, Santo André, São Paulo, Teresina
Age
18 years and over
People
830 worldwide
Run by
AstraZeneca
See details and how to joinNCT06868277 · EU 2024-517780-24-00
No phaseTaking people
RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
Where
Belo Horizonte, Natal, Porto Alegre, São José do Rio Preto, São Paulo
Age
18 years and over
People
250
Run by
AstraZeneca
See details and how to joinNCT06491862
Phase 3Taking people
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Where
São Paulo
Age
18 years and over
People
531 worldwide
Run by
AbbVie
See details and how to joinNCT07365241 · EU 2025-523819-11-00
Phase 2Taking people
Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Where
Ribeirão Preto
Age
18 years and over
People
30
Run by
Hospital das Clínicas de Ribeirão Preto
See details and how to joinNCT07084610
Phase 1/2Taking people
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Where
Barretos, Porto Alegre, Salvador, São José do Rio Preto, São Paulo
Age
18 years and over
People
630 worldwide
Run by
BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00
No phaseNot yet taking people in Brazil
Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)
Where
Rio de Janeiro
Age
50 years to 80 years
People
477
Run by
AstraZeneca
See details and how to joinNCT07279948
No phaseTaking people
Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
Where
Belo Horizonte, Cachoeiro de Itapemirim, Campo Grande, Curitiba, Lages, Londrina, Natal, Porto Alegre, Rio de Janeiro, São Paulo
Age
18 years and over
People
200 worldwide
Run by
Latin American Cooperative Oncology Group
See details and how to joinNCT07192991
No phaseTaking people
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Where
Botucatu
Age
45 years to 74 years
People
1,000
Run by
AstraZeneca
See details and how to joinNCT06376097
Phase 3Taking people
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Barretos, Natal, Porto Alegre, Salvador, São Paulo
Age
18 years and over
People
582 worldwide
Run by
AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00
Phase 2Taking people
A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)
Where
Barretos, Belo Horizonte, Fortaleza, Itajaí, Natal, Porto Alegre, Recife, Rio de Janeiro, Salvador, São José do Rio Preto, São Paulo
Age
18 years and over
People
46
Run by
Latin American Cooperative Oncology Group
See details and how to joinNCT06822543
Phase 3Taking people
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Barretos, Florianópolis, Itajaí, Porto Alegre, Santo André, São José do Rio Preto, São Paulo
Age
18 years and over
People
540 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00
No phaseTaking people
DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
Where
Recife, Rio de Janeiro, Salvador, São Paulo
People
200
Run by
AstraZeneca
See details and how to joinNCT07109154
Phase 1Taking people
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Where
Barretos, Porto Alegre, São Paulo
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00
Phase 2Taking people
Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy
Where
São José do Rio Preto
Age
18 years and over
People
33
Run by
Aline Fusco Fares, MD
See details and how to joinNCT06667154
Phase 2Taking people
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Where
São Paulo
Age
16 years and over
People
100
Run by
AC Camargo Cancer Center
See details and how to joinNCT06472388
No phaseNot yet taking people in Brazil
Protocol for Accelerated Recovery in Patients Undergoing Thoracic Surgical Procedures (PROSM). Study Randomized Comparative Between the Adoption of the Proposed Guidelines and the Traditional Method Currently Used in the Institution
Where
São Paulo
Age
18 years and over
People
200
Run by
Igor Renato Louro Bruno de Abreu
See details and how to joinNCT03271749